New hope for kids with advanced cancer: testing a targeted drug combo
NCT ID NCT02979522
Summary
This study is testing a new drug, brentuximab vedotin, added to standard chemotherapy for children with newly diagnosed, advanced Hodgkin lymphoma. The goal is to see if this combination is safe, effective, and what the best dose is for young patients. The trial enrolled about 59 children in the U.S. and other countries.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliera Citta della Salute e della Scienza di Torino
Torino, 10126, Italy
-
Azienda Ospedaliero Universitaria Ospedale Pediatrico Meyer
Florence, 50139, Italy
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Fondazione IRCCS Policlinico San Matteo
Pavia, 27100, Italy
-
GRAACC - Grupo de Apoio ao Adolescente e a Crianca com Cancer
São Paulo, 04023-062, Brazil
-
Hospital Santa Marcelina
São Paulo, 08270-070, Brazil
-
Hospital Sao Rafael S/A
Salvador, Estado de Bahia, 41253-190, Brazil
-
ICr - Instituto da Crianca - HCFMUSP
São Paulo, 05403-000, Brazil
-
INCA - Instituto Nacional de Cancer
Rio de Janeiro, 20230-230, Brazil
-
Jardim das Americas
Paranã, 81520-060, Brazil
-
NHO Nagoya Medical Center
Nagoya, Aichi-ken, 460-0001, Japan
-
Ospedale Pediatrico Bambino Gesu,UOC Onco-ematologia
Roma, 165, Italy
-
St. Marianna University School of Medicine Hospital
Kawasaki-shi, Kanagawa, 216-8511, Japan
Conditions
Explore the condition pages connected to this study.